Skip to main content

Table 5 The difference of overall survival in cancer patients with high PODXL expression vs low/median expression

From: PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets

Cancer type

No. of cancer tissues

P value

High

Low/Median

Total

ACC

20

59

79

0.37

BLCA

102

304

406

0.34

BRCA

272

809

1081

0.4

CESC

73

218

291

0.77

CHOL

9

27

36

0.57

COAD

69

210

279

0.32

ESCA

46

138

184

0.16

GBM

39

113

152

0.041

HNSCC

130

389

519

0.3

KICH

15

49

64

0.35

KIRC

134

397

531

< 0.0001

KIRP

72

215

287

0.0037

LAML

43

120

163

0.64

LIHC

93

272

365

0.82

LUAD

125

377

502

0.37

LUSC

126

368

494

0.33

DLBC

12

35

47

0.21

MESO

22

63

85

0.23

OVSC

76

227

303

0.95

PAAD

45

132

177

0.013

PCPG

45

134

179

0.13

PRAD

125

372

497

0.92

READ

42

123

165

0.44

SARC

65

194

259

0.12

SKCM

115

344

459

0.22

TGCT

34

100

134

0.29

THYM

30

89

119

0.78

THCA

127

377

504

0.87

UCS

15

41

56

0.58

UCEC

136

407

543

0.006

UVM

20

60

80

0.36

  1. ACC adrenocortical carcinoma, BLCA bladder urothelial carcinoma, BRCA breast invasion carcinoma, CESE cervical squamous cell carcinoma, CHOL cholangiocarcinoma, COAD colon adenocarcinoma, ESCA esophageal carcinoma, GBM glioblastoma multiforme, HNSCC head and neck squamous cell carcinoma, KICH kidney chromophobe, KIRC kidney renal clear cell carcinoma, KIRP kidney renal papillary cell carcinoma, LAML acute myeloid leukemia, LIHC liver hepatocellular carcinoma, LUAD lung adenocarcinoma, LUSC lung squamous cell carcinoma, DLBC lymphoid neoplasm diffuse large B-cell lymphoma, MESO mesothelioma, OVSC ovarian serous cystadenocarcinoma, PAAD pancreatic adenocarcinoma, PCPG pheochromocytoma and paraganglioma, PRAD prostate adenocarcinoma, READ rectum adenocarcinoma, SARC sarcoma, SKCM skin cutaneous melanoma, STAD stomach adenocarcinoma, TGCT testicular germ cell tumors, THYM thymoma, THCA thyroid carcinoma, UCS uterine carcinosarcoma, UCEC uterine corpus endometrial carcinoma, UVM uveal melanoma
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us